Ondine Biomedical, Inc. (VF5) Q2 2023 Earnings Report
DE:VF5 Q2 2023 EPS Results
- Actual EPS
- -EUR 0.03
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.05
DE:VF5 Q2 2023 Revenue Results
- Actual Revenue
- EUR 301.45K
- Expected Revenue
- EUR 266.54K
- Beat/Miss
- Beat by +EUR 34.91K
- YoY Revenue Growth
- +62.02%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 09/25/2023
- Time
- Before Open
- Conference Call
- Monday, September 25, 2023
DE:VF5 Upcoming Earnings
Ondine Biomedical, Inc.'s next earnings date is estimated for May 20, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:VF5 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| May 20, 2027 | 2026 (Q4) | ―- | -0.02 | ― | ― |
| Sep 30, 2026 | 2026 (Q2) | ―-0.02 | -0.02 | 0.00% (+0.00) | |
| Jun 04, 2026 | 2025 (Q4) | ―-0.02 | -0.02 | 9.52% (+0.00) | |
| Sep 26, 2025 | 2025 (Q2) | ―-0.02 | -0.02 | 15.79% (+0.00) | |
| May 15, 2025 | 2024 (Q4) | ―-0.02 | -0.02 | -10.53% (-0.00) | |
| Sep 30, 2024 | 2024 (Q2) | ―-0.02 | -0.03 | 20.83% (+0.01) | |
| Jun 07, 2024 | 2023 (Q4) | ―-0.02 | -0.04 | 47.22% (+0.02) | |
| Sep 25, 2023 | 2023 (Q2) | ―-0.03 | -0.05 | 40.00% (+0.02) | |
| May 10, 2023 | 2022 (Q4) | ―-0.04 | -0.16 | 73.53% (+0.12) | |
| Sep 27, 2022 | 2022 (Q2) | ―-0.02 | -0.01 | -185.71% (-0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed